- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01691911
Preconditioning Shields Against Vascular Events in Surgery (SAVES)
Preconditioning Shields Against Vascular Events in Surgery. A Multi-Centre Trial of Preconditioning Against Adverse Events in Major Vascular Surgery
Study Overview
Status
Intervention / Treatment
Detailed Description
The demand for major vascular surgery is increasing [1]. Patients requiring procedures such as aortic aneurysm repair, carotid endarterectomy, lower limb surgical re-vascularisation and major lower limb amputation for end-stage vascular disease constitute a high-risk surgical cohort. Peri-operative complications such as myocardial infarction, cerebrovascular accident, renal failure and death are common [2,3]. Multiple potential mechanisms may result in these complications. For example, myocardial injury may result from systemic hypotension leading to reduced flow across a tight coronary artery stenosis or, alternatively, it may arise due to acute occlusion when an unstable plaque ruptures. Most strategies aimed at peri-operative risk reduction target a single potential mechanism. For example, beta-blockade may prevent myocardial injury due to overwork, but cannot prevent acute coronary occlusion. There is a requirement for a simple, effective intervention that protects tissues against injury via multiple different mechanisms. Remote ischemic preconditioning (RIPC) may be suitable.
Ischemic preconditioning is a phenomenon whereby a brief period of non-lethal ischemia in a tissue renders it resistant to the effects of a subsequent much longer ischaemic insult. It was first described in the canine heart [4]. Subsequent clinical trials showed that ischemic preconditioning reduced heart muscle damage following coronary artery bypass grafting [5] and liver dysfunction following hepatic resection [6]. Following cardiac surgery, it is associated with a reduction in critical care stay, arrhythmias and inotrope use [7]. However, ischemic preconditioning requires direct interference with the target tissues' blood supply, limiting its clinical utility. Further experimental work suggested that brief ischemia in one tissue, such as the kidneys, could confer protection on distant organs such as the heart [8]. A similar effect was observed after transient skeletal muscle ischemia [9-11]. This effect is referred to as 'preconditioning at a distance' or 'remote ischemic preconditioning' (RIPC).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Limerick, Ireland, 000
- Midwestern Regional Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age greater than 18 years
- patient willing to give full informed consent for participation
- Patients undergoing elective carotid endarterectomy or
- Patients undergoing open abdominal aortic aneurysm repair or
- Patients undergoing endovascular abdominal aneurysm repair or
- Patients undergoing surgical lower limb revascularisation (suprainguinal or infrainguinal)
Exclusion Criteria:
- Patients less than 18 years of age
- Patients who are unable or unwilling to give full informed consent
- Pregnancy
- Significant upper limb peripheral arterial disease
- Patients on glibenclamide or nicorandil (these medications may interfere with remote ischaemic preconditioning)
- Patients with an estimated pre-operative glomerular filtration rate < 30mls/min/1.73m2
- Patients with a history of myocarditis, pericarditis or amyloidosis
- Patients undergoing Fenestrated or branched EVAR.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Remote preconditioning
Preconditioning will be performed in the same manner as several previous trials.
Immediately after induction of anaesthesia, a standard, CE-approved blood pressure cuff will be placed around one arm of the patient.
It will then be inflated to a pressure of 200mmHg for 5 minutes.
For patients with a systolic blood pressure >185mmHg, the cuff will be inflated to at least 15mmHg above the patient's systolic blood pressure.
The cuff will then be deflated and the arm allowed reperfuse for 5 minutes.
This will be repeated so that each patient receives a total of 4 ischaemia-reperfusion cycles.
In all other respects, the procedure and peri-operative care will follow the routine practices of the surgeons and anaesthetists involved.
|
Immediately after induction of anaesthesia, a standard, CE-approved tourniquet cuff will be placed around one arm of the patient.
It will then be inflated to a pressure of 200mmHg for 5 minutes.
For patients with a systolic blood pressure >185mmHg, the cuff will be inflated to at least 15mmHg above the patient's systolic blood pressure.
The cuff will then be deflated and the arm allowed reperfuse for 5 minutes.
This will be repeated so that each patient receives a total of 4 ischaemia-reperfusion cycles.
In all other respects, the procedure and peri-operative care will follow the routine practices of the surgeons and anaesthetists involved.
|
No Intervention: Remote preconditioning control
Patients randomised to this group will receive routine pre-operative, peri-operative and post operative care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Major Adverse Clinical Events
Time Frame: 30 day
|
The primary endpoint for the trial will be Major Adverse Clinical Events.
This is a composite endpoint comprising any of: cardiovascular death, myocardial infarction, new onset arrhythmia requiring treatment, cardiac arrest, congestive cardiac failure, cerebrovascular accident, renal failure requiring renal replacement therapy, mesenteric ischaemia requiring intervention or biopsy proven ischaemic colitis, urgent cardiac revascularisation.
All participants will undergo a serum troponin levels and 12-lead electrocardiogram on the second post-operative day to screen for silent peri-operative myocardial infarction.
Trial ECGs and troponin levels will be interpreted by a blinded trial cardiologist.
|
30 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Duration of post-operative hospital stay
Time Frame: 30 day
|
The duration of hospital stay and ITU stay have a major impact on health service resource utilisation, and are factors which can be influenced by surgery.
|
30 day
|
Duration of intensive care unit stay
Time Frame: 30 day
|
The duration of hospital stay and ITU stay have a major impact on health service resource utilisation, and are factors which can be influenced by surgery.
|
30 day
|
Unplanned critical care unit admission
Time Frame: 30 day
|
The duration of hospital stay and ITU stay have a major impact on health service resource utilisation, and are factors which can be influenced by surgery.
|
30 day
|
Acute kidney injury score in first three peri-operative days
Time Frame: 3 days
|
The Acute Kidney Injury Score will be calculated over the first three peri-operative days.
Creatinine will be measured daily as part of routine care.
Urine volumes will be calculated from the fluid balance charts maintained as part of usual care.
|
3 days
|
Peri-operative myocardial injury
Time Frame: from operation to 72 hours postoperatively
|
Peri-operative myocardial injury will be assessed by measurement of serum troponin levels.
This will be achieved by comparing area under the curve (AUC) for serum troponin concentration over the first three post-operative days.
|
from operation to 72 hours postoperatively
|
Collaborators and Investigators
Investigators
- Principal Investigator: Stewart R Walsh, MCh FRCS, Mid Western Regional Hospital and University of Limerick
Publications and helpful links
General Publications
- Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986 Nov;74(5):1124-36. doi: 10.1161/01.cir.74.5.1124.
- Greenhalgh RM, Brown LC, Kwong GP, Powell JT, Thompson SG; EVAR trial participants. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet. 2004 Sep 4-10;364(9437):843-8. doi: 10.1016/S0140-6736(04)16979-1.
- Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, Vogel M, Sorensen K, Redington AN, MacAllister R. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation. 2002 Dec 3;106(23):2881-3. doi: 10.1161/01.cir.0000043806.51912.9b.
- Anderson PL, Gelijns A, Moskowitz A, Arons R, Gupta L, Weinberg A, Faries PL, Nowygrod R, Kent KC. Understanding trends in inpatient surgical volume: vascular interventions, 1980-2000. J Vasc Surg. 2004 Jun;39(6):1200-8. doi: 10.1016/j.jvs.2004.02.039.
- Chambers BR, Donnan GA. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev. 2005 Oct 19;2005(4):CD001923. doi: 10.1002/14651858.CD001923.pub2.
- Jenkins DP, Pugsley WB, Alkhulaifi AM, Kemp M, Hooper J, Yellon DM. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart. 1997 Apr;77(4):314-8. doi: 10.1136/hrt.77.4.314.
- Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, Jochum W. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg. 2003 Dec;238(6):843-50; discussion 851-2. doi: 10.1097/01.sla.0000098620.27623.7d.
- Walsh SR, Tang TY, Kullar P, Jenkins DP, Dutka DP, Gaunt ME. Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials. Eur J Cardiothorac Surg. 2008 Nov;34(5):985-94. doi: 10.1016/j.ejcts.2008.07.062. Epub 2008 Sep 9.
- Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993 Mar;87(3):893-9. doi: 10.1161/01.cir.87.3.893.
- Birnbaum Y, Hale SL, Kloner RA. Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation. 1997 Sep 2;96(5):1641-6. doi: 10.1161/01.cir.96.5.1641.
- Oxman T, Arad M, Klein R, Avazov N, Rabinowitz B. Limb ischemia preconditions the heart against reperfusion tachyarrhythmia. Am J Physiol. 1997 Oct;273(4):H1707-12. doi: 10.1152/ajpheart.1997.273.4.H1707.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Aortic Diseases
- Ischemia
- Carotid Artery Diseases
- Atherosclerosis
- Aneurysm
- Aortic Aneurysm
- Aortic Aneurysm, Abdominal
Other Study ID Numbers
- SAVES-123
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carotid Atherosclerosis
-
Universidade Camilo Castelo BrancoCompletedSubclinical Carotid Atherosclerosis
-
Silk Road MedicalCompletedCarotid Artery Plaque | Carotid Stenosis | Carotid Artery Diseases | Carotid Atherosclerosis | Carotid DiseaseUnited States, Spain
-
University of PennsylvaniaMerck Sharp & Dohme LLC; The Dana Foundation; Kos PharmaceuticalsCompletedEstablished Carotid Atherosclerosis
-
Sohag UniversityRecruitingCarotid Artery Plaque | Carotid Stenosis | Carotid AtherosclerosisEgypt
-
Linkoeping UniversityRegion Östergötland; Region Jönköping County; FORSS, Forskningsrådet i Sydöstra...CompletedCarotid Artery Plaque | Carotid Stenosis | Carotid Atherosclerosis
-
Silk Road MedicalTechnical University of Munich; University Ghent; Complejo Hospitalario ToledoCompletedThe ENROUTE Transcarotid Neuroprotection System (ENROUTE Transcarotid NPS) DW-MRI Study (DW-MRI OUS)Carotid Artery Plaque | Carotid Stenosis | Carotid Artery Diseases | Carotid AtherosclerosisBelgium, Spain, Germany
-
Abbott Medical DevicesCompletedCarotid Atherosclerosis | Carotid Artery Disease
-
Azienda Ospedaliero-Universitaria di ModenaCompletedStroke | Carotid Artery Plaque | Carotid Stenosis | Carotid Artery Diseases | Carotid Atherosclerosis | TCDItaly
-
Peking UniversityCompletedCarotid Atherosclerosis | Carotid Intimal Medial Thickness 1China
-
Azienda Ospedaliero, Universitaria PisanaUniversity Medical Center Groningen; Azienda USL Toscana Nord Ovest; University... and other collaboratorsRecruitingCarotid Artery Plaque | Carotid Artery Diseases | Carotid AtherosclerosisItaly
Clinical Trials on Remote preconditioning
-
Tartu University HospitalCompletedAtherosclerosis | Stable Angina | Peripheral Artery Disease | Contrast-induced NephropathyEstonia
-
University College London HospitalsCompletedCoronary Heart DiseaseUnited Kingdom
-
University of NottinghamRecruitingVascular Diseases | HypertensionUnited Kingdom
-
St. Francis Hospital, New YorkTerminatedCoronary Artery DiseaseUnited States
-
Capital Medical UniversityPeking University First HospitalCompletedCerebral Small Vessel DiseaseChina
-
Azienda Ospedaliera Città della Salute e della...CompletedAcute Kidney InjurySpain, France, Italy
-
St. Josefs-Hospital Wiesbaden GmbHRecruitingAtrial FibrillationGermany
-
Medical University of LodzCompletedRemote Ischemic Preconditioning | Contrast Induced - Acute Kidney InjuryPoland
-
University of MiamiCompletedSubarachnoid Hemorrhage